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Abstract 
Swine dysentery caused by Brachyspira hyodysenteriae, results in substantial economic losses in swine producing 
countries worldwide. Although a number of different vaccine approaches have been explored with regard to this dis-
ease, they show limitations and none of them have reached the market. We here determine the vaccine potential of a 
weakly haemolytic B. hyodysenteriae strain. The virulence of this strain was assessed in experimental infection trials and 
its protection against swine dysentery was quantified in a vaccination-challenge experiment using a seeder infection 
model. Systemic IgG production and local IgA production were monitored in serum and faeces respectively. Across all 
trials, pigs that were colonized by virulent, strongly haemolytic B. hyodysenteriae strains consistently developed swine 
dysentery, in contrast to none of the pigs colonized by the weakly haemolytic B. hyodysenteriae vaccine strain. In the 
seeder vaccination trial nearly all immunised animals developed swine dysentery on subsequent challenge with a 
virulent strain, but the speed of spread of swine dysentery and faecal score were significantly reduced in animals 
immunised with the weakly haemolytic strain compared to sham-immunised animals. The IgA response of immu-
nised animals upon challenge with a virulent B. hyodysenteriae strain significantly correlated to a later onset of disease. 
The correlation between local IgA production and protection induced by a weakly haemolytic B. hyodysenteriae strain 
provides leads for future vaccine development against swine dysentery.
© The Author(s) 2017. This article is distributed under the terms of the Creative Commons Attribution 4.0 International License 
(http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, 
provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, 
and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/
publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
Introduction
Swine dysentery (SD) caused by Brachyspira hyodysente-
riae (B. hyodysenteriae), results in substantial economic 
losses in swine producing countries worldwide. Major 
costs associated with SD comprise medical treatment, 
retarded growth and increased feed conversion [1]. Treat-
ment with antimicrobial compounds is hampered due to 
increasing resistance against lincosamides, pleuromuti-
lins and macrolides which are the most widely used com-
pounds against SD [2–4]. Besides instigating therapeutic 
failure, there is growing public concern against the use 
of antibiotics in animal production in general because it 
may favour spread of antimicrobial resistance in different 
bacterial species, including zoonotic agents [5, 6]. The 
impact of SD on swine health and production, increas-
ing therapeutic failure of antimicrobial treatment and 
the need for a reduction of the use of antimicrobial com-
pounds urge for alternative control measures against SD.
The immunological response in pigs that recovered 
from SD has been shown to protect against subsequent 
challenge with B. hyodysenteriae [7]. Therefore, a number 
of different vaccination approaches have been explored 
with regard to SD. Several reports describe the use of 
whole cell bacterins [8–12] or protein digests of whole 
cell bacterins [13–15]. Some of these bacterins, admin-
istered intramuscularly or intravenously, induce partial 
protection, demonstrated by a lower proportion of ani-
mals developing clinical SD, or animals developing less 
severe disease signs of SD [8–10, 16]. In contrast, Olson 
et  al. [12] described animals developing a more severe 
form of SD with an earlier onset after vaccination with 
Open Access
*Correspondence:  frank.pasmans@ugent.be 
Department of Pathology, Bacteriology and Avian Diseases, 
Faculty of Veterinary Medicine, Ghent University, Salisburylaan 133, 
9820 Merelbeke, Belgium
Page 2 of 13Mahu et al. Vet Res  (2017) 48:59 
an inactivated B. hyodysenteriae vaccine. A major down-
side of the use of inactivated whole cell bacterins is that 
they usually only evoke protection against infection with 
a homologous serotype of B. hyodysenteriae [1].
Vaccination with recombinant proteins has been 
reported to induce variable levels of protection, depend-
ing on the selected protein. The use of a recombinant 
flaB1 flagellar protein could not reduce the number of 
pigs developing SD after challenge with a virulent B. hyo-
dysenteriae strain [17]. A preparation of BmpB, an outer 
membrane lipoprotein, resulted in a 50% reduction in 
clinical SD [18]. Song et al. [19] described a reverse vac-
cinology approach to select proteins for use in a subunit 
vaccine. They also reported a reduction in number of ani-
mals developing clinical SD, albeit not significant.
DNA vaccines based on ftnA, encoding a putative fer-
ritin protein, or SmpB, encoding a protein with unknown 
function, failed to protect mice against challenge with a 
virulent B. hyodysenteriae strain [20, 21]. The use of DNA 
vaccines for SD has not been investigated in pigs. A tlyA 
mutant strain of B. hyodysenteriae has been examined for 
its use as a live attenuated vaccine. A 50% reduction in 
the number of animals developing clinical SD upon chal-
lenge with a virulent B. hyodysenteriae strain was demon-
strated. However, there was no reduction in the number 
of animals that was colonised by the challenge strain [22].
Despite all these efforts, an efficient vaccine against B. 
hyodysenteriae is currently not available. Recently, we iso-
lated a weakly haemolytic B. hyodysenteriae strain which 
appeared to be less virulent than strongly haemolytic B. 
hyodysenteriae strains [23]. In this study we explore this 
strain’s vaccination potential by verifying its virulence in 
pigs and determining the extent of protection it provides 
against SD in an experimental infection trial.
Materials and methods
The animal experiments were approved by the Ethi-
cal Committee of the Faculty of Veterinary Medicine, 
Ghent University, Belgium (EC 2012/01, EC 2013/147, 
EC2014/130, EC2015/22, EC2015/134) and complied 
with all ethical and husbandry regulations.
Brachyspira hyodysenteriae strains and growth conditions
Three B. hyodysenteriae field strains and the strongly 
haemolytic reference strain B204 (ATCC32121) were 
used in the experimental infection trials: weakly haemo-
lytic strain D28 and strongly haemolytic strain 8dII are 
two field strains which have been described previously 
[23]. Strongly haemolytic strain 49 was isolated in this 
study from seeder animals that were purchased from 
a commercial source suffering an acute outbreak of SD. 
Strains and their strength of haemolysis are given in 
Table  1. Strength of haemolysis was determined as vis-
ible haemolysis of growth on blood supplemented culture 
plates and by in vitro quantification as described in a pre-
vious study [23].
For the virulence trials, strains were obtained from fro-
zen stocks, thawed and grown on Tryptic Soy Agar (BD, 
Heidelberg, Germany), supplemented with 5% sheep 
blood (IMP, Brussels, Belgium) and 1% yeast extract 
(Oxoid, Aalst, Belgium) [24]. Strains were subcultured 
twice and suspensions were prepared by harvesting a 
4-day-old culture plate with a sterile cotton swab and 
stirring the cotton swab in 50 mL of an anaerobic Brain 
Heart Infusion (BHI) broth, supplemented with 10% of 
Foetal Bovine Serum (FBS). The broth was incubated 
anaerobically during 40 h on a rocking platform at 37 °C. 
After incubation, cultures were microscopically exam-
ined for purity and each animal was administered 40 mL 
of B. hyodysenteriae culture which contained approxi-
mately 1  ×  108 colony forming units per mL. For the 
seeder vaccination trial, cultures were obtained in grossly 
the same way as for the virulence trials except that bacte-
ria were grown in BHI broth with 10% FBS for 30 h, after 
which the anaerobe broth was centrifuged at 1500 g for 
20 min and the pellet was suspended in a volume leading 
to a final concentration of approximately 1 × 109 B. hyod-
ysenteriae per mL.
Table 1 Brachyspira hyodysenteriae strains, experimental set-up and results for faecal excretion and clinical signs of SD
a Given as proportion of total number of inoculated pigs.
Virulence  
trial number
B. hyodysenteriae 
strain
Strength  
of haemolysis
Model and inoculation 
route
Number of pigs 
positive for faecal 
 excretiona
Number of pigs 
with  SDa
1 8dII Strong Direct oral inoculation 2/6 2/6
2 B204 Strong Direct gastric inoculation 5/9 5/9
3 49 Strong Seeder model 5/14 4/14
4 D28 Weak Direct oral inoculation 5/8 0/8
5 D28 Weak Direct gastric inoculation 4/12 0/12
Seeder vaccination 
experiment
D28 Weak Direct oral inoculation 25/30 0/30
Page 3 of 13Mahu et al. Vet Res  (2017) 48:59 
Virulence trials
In order to determine the in  vivo virulence of different 
B. hyodysenteriae strains, several experimental infection 
trials were conducted. The correlation between faecal 
shedding, as a proxy of intestinal colonization, and fae-
cal score, as a measure for the development of SD, was 
determined independently for the four different B. hyo-
dysenteriae strains in five experimental infection trials. 
Experiments were conducted separately in different time 
periods. In each experiment a single strain was used. 
Strain D28 was used in two independent experiments.
Experimental set-up The five experimental set-ups are 
presented in Table 1. In all set-ups, experimental animals 
were purchased from commercial sources with no prior 
history of SD. On arrival, faeces were collected from all 
individual animals and examined for the presence of Sal-
monella sp. by microbial culture as previously described 
[25] and for the presence of B. hyodysenteriae by micro-
bial culture and qPCR [26]. All animals were fed a com-
mercial starter feed ad libitum.
Experimental procedures Inoculation was performed 
on three consecutive days and was preceded by a 12  h 
fast. Inoculation was performed orally or intragastri-
cally as given in Table  1. For intragastric inoculation, 
animals were anaesthetized by intramuscular injection 
with a combination of xylazine at 4.4  mg/kg (Xyl-M 
2%®, VMD, Arendonk, Belgium) and zolazepam/tileta-
mine at 2.2 mg/kg  (Zoletil® 100, Virbac, Carros, France). 
All intragastrically inoculated animals were pretreated 
90  min before inoculation with 0.75  mg/kg ranitidine 
(Zantac™, GlaxoSmithKline, Genval, Belgium) to reduce 
stomach acid production.
In experiment 3 instead of direct inoculation, the con-
tact animals (receivers) were placed in the same unit with 
animals that were shedding B. hyodysenteriae and had 
been confirmed to have SD (seeders). These seeder ani-
mals were purchased from a commercial source suffering 
an acute outbreak of SD. Strain 49 was isolated from fae-
cal samples of those pigs.
Follow-up In all trials, animals were observed daily 
for the presence of diarrhoea and other disease signs. 
Two to three times a week, faeces were scored and stool 
samples were collected. Faecal scores were determined 
as 0: normal, 1: softer but formed, 2: unformed semi-
wet, 3: runny, 4: runny with mucus and blood. Scores 
2 and 3 were supplemented with 0.5 if blood or mucus 
were present. DNA was extracted from the stool sam-
ples using a Qiagen Stool Mini Kit (Qiagen, Hilden, Ger-
many) and the extracted DNA was used to determine 
the quantity of B. hyodysenteriae DNA with qPCR [26]. 
Correlation between faecal excretion of the strain used 
for inoculation and faecal score was determined for each 
experiment.
At the end of the trial (3–5 weeks after inoculation) or 
24 h (trial 2) after the first signs of swine dysentery, ani-
mals were euthanized. During necropsy, tissue samples 
of the apex of the colon were collected in 10% buffered 
formalin for histology during necropsy. Animals were 
anaesthetized with a combination of xylazine at 4.4 mg/
kg (Xyl-M 2%®, VMD, Arendonk, Belgium) and zolaze-
pam/tiletamine at 2.2  mg/kg  (Zoletil® 100, Virbac, Car-
ros, France). They were euthanized by administering an 
overdose of pentobarbital  (Release®, 45 mg/kg; Ecuphar, 
Oostkamp, Belgium) by intracardial injection. Fixed sam-
ples were paraffin embedded, sectioned at 5–8  µm and 
stained with hematoxylin and eosin or with Periodic Acid 
Schiff reagent (PAS).
Vaccination trials
In the seeder vaccination trial, non-virulent B. hyodysen-
teriae strain D28 was used as the immunising strain, and 
virulent B. hyodysenteriae strain B204 as the challenge 
strain. Sixty, 6-week-old male and female piglets were 
purchased from a commercial source with no previous 
history of SD. On arrival, animals were weighed and ran-
domly assigned to six groups; three immunisation groups 
(10 animals each) and three non-immunisation groups 
(10 animals each). Individual faecal samples were taken 
to confirm absence of B. hyodysenteriae by microbial cul-
ture and qPCR. All animals were fed a commercial starter 
feed ad libitum.
After a 9-day acclimatization period, animals in the 
immunisation groups were orally inoculated as described 
for the virulence trials on three consecutive days (day 
−2, day −1, day 0) with 20  mL of a culture containing 
approximately  109 colony forming units (cfu)/mL of non-
virulent strain D28. Correspondingly, animals in the non-
immunisation groups were orally inoculated with 20 mL 
of BHI broth supplemented with 10% FBS. All animals 
were pre-treated 90 min before inoculation with 0.75 mg/
kg ranitidine (Zantac™, GlaxoSmithKline, Genval, Bel-
gium) to reduce stomach acid production.
Three weeks after (sham-)immunisation, five animals of 
each group were challenged with virulent B. hyodysente-
riae strain B204 on three consecutive days by oral inocu-
lation (day 19, day 20, day 21) as described above for the 
immunising strain. These challenged animals served as 
seeder animals for the remaining five animals (receivers) 
in each group.
Animals were observed daily for the presence of diar-
rhoea and other disease signs. During the period post-
immunisation until challenge, faecal samples were 
collected three times a week from immunised ani-
mals. From these faecal samples DNA was extracted as 
described above to determine excretion of the immunis-
ing strain and faeces were scored as described for the 
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virulence trials. These faecal samples were also used to 
determine the presence of faecal IgA against B. hyodysen-
teriae. Faecal samples from non-immunised animals were 
collected once during this period to confirm the absence 
of B. hyodysenteriae and faecal IgA against B. hyodysente-
riae. After challenge, faecal samples were taken two times 
a week from all animals. These samples were scored and 
DNA was extracted to determine the excretion of the 
immunising and/or challenge B.  hyodysenteriae strain. 
These faecal samples were used to determine the pres-
ence of faecal IgA against B. hyodysenteriae as well.
Animals were weighed at the start of the trial (before 
immunisation), after immunisation at day 17 and at nec-
ropsy. Average daily weight gain was calculated for each 
individual animal. Blood samples for determination of 
the presence of B.  hyodysenteriae reactive serum IgG 
were taken before immunization (day −13) and before 
challenge (day 17).
Animals were euthanized at day 50–52 (30–32  days 
post challenge) or sooner if apathy or depression was 
noted. Euthanasia was performed as described for the 
virulence trials.
qPCR differentiating between the immunising and the 
challenge strain
In order to specifically determine the quantity of B. hyo-
dysenteriae DNA of the immunising strain and the chal-
lenge strain in faecal and intestinal samples, primers 
were designed to specifically anneal with DNA of either 
strain. Primers were based on the haemolysin III gene 
from both strains: D28 (GenBank KU215635) and B204 
(GenBank JXND01000108) [23, 27]. Following primers 
were used for specific detection of the immunising strain 
D28: HlyVacFo 5′TGGTGAAATACTGCCAAAA3′ and 
HlyVacRe 5′TGTTGTTATATCGTCCATAC3′. Follow-
ing primers were used to specifically detect the challenge 
strain: HlyInfFo 5′GTTAATGCTGAAAAAATGATG3′ 
and HlyInfRe 5′AAGCTCTTGTATGGAATATAC3′. For 
both strains, following primer pair was used to generate 
an amplicon to be used as a standard: HlySTFo 5′CAA-
GTTCTATGATACCTAC3′ and HlySTRe 5′GCCGC-
CTTTAACATAYTCTTT3′. The quantitative PCR was 
performed on a CFX96™ RT-PCR System with a C1000 
Thermal Cycler (Bio-Rad, Hercules CA, USA). Two μL of 
DNA was suspended in a 10 μL reaction mixture consist-
ing of SensiMix™ SYBR No-ROX (Bioline Reagents Ltd, 
UK), HPLC water and primers at 1.5 µM for the challenge 
strain, and at 0.5 µM for the immunising strain. The PCR 
program consisted of denaturation for 10  min at 95  °C, 
followed by 40 cycles of 95 °C for 30 s, and 60 °C for 30 s. 
Standards and samples were run in duplicate. Reactions 
for both strains were performed separately, since both 
amplicons generated a melt temperature of 74.5  °C and 
could not be distinguished based on their melt tempera-
tures. The Bio-Rad CFX Manager (version 1.6) software 
was used for calculation of threshold cycles (Ct)-values 
and melting curve analysis of amplified DNA.
Enzyme‑linked immuno sorbent assay (ELISA) for specific 
detection of serum IgG and faecal IgA against B. 
hyodysenteriae
For detection of antibodies against B.  hyodysenteriae 
strains D28 or B204, in-house whole cell ELISAs were 
prepared for both strains as described previously for Sal-
monella enterica [28]. Each strain was grown in BHI with 
10% FBS for 48 h on a rocking platform at 37 °C. Cultures 
were inactivated by adding 0.18% (v/v) formalin. The 
inactivated B. hyodysenteriae suspensions were washed 
with phosphate buffered saline (PBS) with 0.18% forma-
lin (v/v) and finally resuspended in coating buffer (1.08 g 
 Na2CO3·10H2O, 0.968 g  NaHCO3, 0.25 L aqua ad injecta-
bilia 100% w/v). F96 Nunc-immuno plates (Nunc Inter-
national, Roskilde, Denmark) were coated with 140  µL 
of inactivated B. hyodysenteriae in coating buffer, diluted 
to an optical density of 0.3 at 660 nm. After a 24 h-incu-
bation period at 4  °C, plates were washed three times 
with 100 µL of wash buffer (0.6 g  NaH2PO4·2H2O, 5.6 g 
 NaH2PO4·12H2O, 0.5 mL Tween 20, 12.5 g NaCl). Plates 
were kept at 4 °C until further use.
Wells were pre-incubated with 1% skim milk pow-
der solution in distilled water for 15  min to block non-
specific binding. For detection of IgG in serum samples, 
100 µL of 1/200 diluted sera were added to the wells and 
incubated for 30 min at room temperature. After incuba-
tion, wells were washed five times with wash buffer after 
which 100 µL of a 1/20 000 dilution of a horseradish per-
oxidase conjugated anti-porcine IgG (Sigma-Aldrich, St. 
Louis, MO, USA) was added. After 30 min of incubation 
wells were washed five times with wash buffer and 100 µL 
3,3′,5,5′-tetramethylbenzidine (Sigma-Aldrich, St. Louis, 
MO, USA) reagent was added. The enzymatic reaction 
was stopped after 10 min by adding 100 µL of 1 N HCl. 
Optical densities were measured with a spectrophotom-
eter (Multiskan MS, Thermofisher Scientific, Waltham, 
MA, USA) at 450 nm.
For detection of IgA in faecal samples, extracts were 
prepared as described by Peeters et al. [29]. One gram of 
frozen faeces was weighed and placed on ice. Three mL 
of extraction buffer (PBS, 0.5% Tween 20%, 0.05%  NaN3) 
was added and the suspension was centrifuged at 4  °C 
for 20 min at 1500 g. The supernatant was collected in a 
2 mL Eppendorf tube (Eppendorf, Hamburg, Germany). 
Twenty µL of proteinase inhibitor (Sigma-Aldrich, St. 
Louis, MO, USA) was added before centrifugation for 
10 min at 3000 g at 4 °C. Supernatant was collected and 
stored at −20  °C until further use. For detection of IgA 
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reactive with B.  hyodysenteriae in these faecal extracts, 
ELISA was carried out as for IgG detection in serum with 
following changes: faecal extracts were used undiluted 
and were incubated for 60 min, the secondary antibody, 
goat anti-porcine IgA (Bio-rad, Kidlington, UK) was used 
in a 1/5000 dilution.
Statistical analysis
Correlation between faecal excretion and faecal score 
was determined by Spearman’s rank order correlation (r) 
and was performed with SPSS 22.0 software (SPSS Inc, 
Chicago, USA). In the seeder vaccination model, faecal 
scores were analysed using cumulative logit link regres-
sion. Interactions between time, type and treatment 
were included, as well as random effects at the individual 
level, to control for pseudo-replication in the individual 
time series, and at the pen effect to account for cluster-
ing. The analysis was performed using package “ordinal” 
in R. Analysis was repeated for faecal excretion, this time 
using a linear mixed model (package “lme4” in R), with 
the same predictors as above.
The effect of treatment on average daily weight gain 
was analysed using linear regression. The effect of faecal 
IgA response on the time of onset of SD was analysed in 
two steps. First, measurements for individual animals, 
collected at regular intervals (3, 6, 10, 13, and 17  days 
post challenge), were analysed using a survival model, 
estimating whether the probability of an individual devel-
oping SD was delayed by a stronger faecal IgA response. 
The use of the survival model enabled us to account for 
censoring (some individuals had not developed disease 
by the time the experiment was terminated). To capture 
several possibilities, the analysis of the survival model 
was repeated using as response variable alternatively the 
maximum IgA value, the arithmetic mean and the geo-
metric mean across all days before the first notice of dis-
ease signs for a given individual. The geometric mean was 
used to better reflect the possible dependency between 
successive measures of IgA in the same individual. All 
three survival models included a fixed effect for individ-
ual type (seeder/receiver) and a random effect at the pen 
level to account for clustering. All analyses of faecal IgA 
responses were carried out using the “survival” package 
in R. For all analyses, the statistical significance level was 
set at α = 0.05.
Results
The low haemolytic B. hyodysenteriae strain D28 is 
avirulent in pigs
In all virulence trials, faeces of all animals were negative 
for B.  hyodysenteriae on arrival, although some animals 
of each trial tested positive for B. innocens. All animals 
tested negative for Salmonella. Across all infection trials, 
out of 12 pigs that were colonized by strongly haemolytic 
B. hyodysenteriae strains, 11 consistently developed SD, 
in contrast to none of the 34 pigs colonized by the weakly 
haemolytic strain D28 (Table 1). One receiver animal in 
experiment 3 shed B. hyodysenteriae in its faeces on two 
occasions at the end of the trial. At the same time the ani-
mal had a faecal score of 2. It is possible that this animal 
would have developed SD in the following days. How-
ever, since the trial ended simultaneously for all animals 
in that trial, the animal was euthanized and the develop-
ment of SD could not be confirmed.
In the seeder vaccination trial, during the period 
between immunisation with strain D28 and the challenge 
with the virulent strain, no clinical signs of dysentery 
were noticed in any animal. On all sampling occasions, 
maximum faecal score was 1. Score 1 was noted in immu-
nised as well as in non-immunised animals.
Figure  1 shows the correlation between faecal excre-
tion and faecal scores for weakly haemolytic strain D28 
(Figures 1A–C) and for strongly haemolytic strains 8dII 
(Figure 1D), 49 (Figure 1E) and B204 (Figure 1F). The cor-
relation between faecal excretion and faecal scores was 
significant (p < 0.01) for the strongly haemolytic strains 
and the correlation coefficients (r) were 0.67 (strain 8dII), 
0.40 (strain 49) and 0.64 (strain B204) respectively. For 
weakly haemolytic strain D28 there was no correlation 
between faecal excretion and faecal score in any of the 
experiments; experiment 4 r = 0.049, p = 0.684, experi-
ment 5 r = −0.064, p = 0.536, seeder vaccination experi-
ment r = −0.007, p = 0.919.
All animals, inoculated with one of the strongly 
haemolytic B.  hyodysenteriae strains, that showed clini-
cal signs of SD had various lesions in large parts of the 
colon. Contents of the colon were liquid and macro-
scopic lesions consisted of serosal hyperaemia, fibrinous 
colitis, enlarged mesenteric lymph nodes and the pres-
ence of excessive mucus at the colonic mucosa. Histo-
logically, elongation of the colonic crypts and presence of 
a large amount of mucoid material in the lumen of the 
infected animals were remarkable. The lamina propria 
mucosae was infiltrated by lymphocytes, plasma cells, 
and neutrophils.
Of the animals that shed weakly haemolytic B. hyod-
ysenteriae strain D28, some showed slight hyperaemia of 
the colonic mucosa but no other apparent macroscopic 
lesions were observed. Histologically, no elongation 
of the colonic crypts was observed and no infiltration 
of inflammatory cells could be observed in the lamina 
propria.
PAS staining showed elongation of the colonic crypts 
and a high number of Goblet cells in animals colonized 
with a strongly haemolytic strain (Figure  2B; animal 
colonized with strongly haemolytic strain 8dII as an 
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example), but not in those colonized with the weakly 
haemolytic strain D28 (Figure 2C) or in negative control 
animals (Figure 2A).
Vaccination with the avirulent strain delays the spread 
of SD
In the seeder vaccination trial, of the 30 animals inocu-
lated with immunising strain D28, the majority shed the 
strain in their faeces for less than 1 week (12 animals) or 
less than 2  weeks (10 animals). Three animals shed the 
strain for more than 2 weeks and for five animals, strain 
D28 could not be detected with qPCR throughout the 
experiment. Most animals (18 out of 25) started shed-
ding strain D28 in their faeces within the first week after 
inoculation, six animals in the second week, and one ani-
mal at 17 days post inoculation. During the period post 
vaccination until challenge vaccinated animals had a sig-
nificantly lower average daily weight gain compared to 
sham-vaccinated animals (linear regression coefficient 
for treatment: β = −0.52 ± 0.2 SE, p = 0.010).
The total number of animals that developed SD after 
challenge with the virulent B. hyodysenteriae strain is 
given in Figure  3. At the end of the trial 28/30 animals 
had developed SD in the immunised group as well as 
Figure 1 Correlation between faecal excretion of the different B. hyodysenteriae strains used for inoculation and faecal scores of pigs 
inoculated with these strains. A, B Weakly haemolytic B. hyodysenteriae strain D28 in experiments nr 4 and 5, C weakly haemolytic B. hyodysen-
teriae strain D28 in the seeder vaccination experiment, D strongly haemolytic B. hyodysenteriae strain 8dII in experiment nr 1, E strongly haemolytic 
B. hyodysenteriae strain 49 in experiment nr 3, F strongly haemolytic B. hyodysenteriae strain B204 in experiment nr 2. n = total number of inoculated 
pigs in each experiment.
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in the non-immunised group. The onset of SD, defined 
as the first day on which a faecal score of 2.5 or more 
was reached and mucus and/or blood were present, 
was postponed in immunised animals compared to 
non-immunised animals. There was a significant inter-
action between immunisation and number of days 
from challenge until onset of SD (regression estimate 
β = 0.065 ± 0.022 SE, p = 0.004). Seeder animals in the 
immunisation groups developed SD on average after 11.1 
(10–11.8) days while seeder animals in the non-immu-
nisation groups developed SD on average after 9.2  days 
(7.6–12). Receiver animals developed SD on average after 
21.2 days (18.8–22.4) in the immunised groups, and after 
17.3 days (15.6–20.25) in the non-immunised groups.
The average cumulative faecal score of pigs after chal-
lenge with virulent B. hyodysenteriae strain B204 is 
given in Figure  4. The main effects in the regression 
showed that the probability of having a higher faecal 
score decreased with immunisation (regression coef-
ficient: β = −1.398 ±  0.384  SE, p =  0.0002), indicating 
that immunisation significantly reduced the probability 
of having a higher faecal score.
We did not find a significant correlation between 
immunisation and the faecal excretion of the challenge 
Figure 2 PAS staining of formalin fixed colonic tissue samples of pigs infected with different B. hyodysenteriae strains. Colonic mucosa 
from A sham inoculated animal, B animal infected by strongly haemolytic B. hyodysenteriae strain 8dII (33 days post inoculation), C animal infected 
by weakly haemolytic B. hyodysenteriae strain D28 (32 days post inoculation).
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Figure 3 Cumulative number of pigs that developed SD after challenge with virulent B. hyodysenteriae strain B204, preceded either 
(circles) or not (squares) by exposure to non-virulent B. hyodysenteriae strain D28.
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strain (all p  >  0.3). Faecal excretion of the challenge 
strain was correlated with faecal scores, and equally 
strong for vaccinated and non-vaccinated animals (vac-
cinated animals r = 0.79, p < 0.001, non-vaccinated ani-
mals r = 0.74, p < 0.001). In all weight gain analyses, no 
significant differences were found between seeders and 
receiver individuals. Although a trend could be observed 
for immunised animals, most noticeable for receiver 
animals, to have a higher weight gain in the post chal-
lenge period compared to non-immunised animals, this 
difference was not significant (p = 0.17). Plots of average 
daily weight gain are given in Figure 5.
The avirulent strain does not induce a fast IgG response
Serum IgG ELISA responses against B. hyodysenteriae 
are given in Table  2. There was no significant increase 
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Figure 4 Average cumulative faecal score of pigs after challenge with virulent B. hyodysenteriae strain B204, preceded either (circles) 
or not (squares) by exposure to non-virulent B. hyodysenteriae strain D28.
Figure 5 Plots of average daily weight gain (period: post-vaccination to necropsy), of pigs after challenge with virulent B. hyodysen-
teriae strain B204, preceded either (green) or not (yellow) by exposure to non-virulent B. hyodysenteriae strain D28, grouped by 
individual type (seeder, receiver and both) and by vaccination treatment. Boxes indicate 25 and 75% quantiles: bars indicate 2.5 and 97.5% 
quantiles. Average daily weight gain given in kg.
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of IgG post-vaccination either for vaccinated or non-
vaccinated animals, regardless of which strain was used 
to coat the whole cell ELISA. There were no significant 
differences between vaccinated and non-vaccinated ani-
mals, before or after vaccination.
The avirulent strain induces a local yet variable IgA 
response
During the period post-vaccination and before challenge 
with the virulent B.  hyodysenteriae strain, faecal IgA 
increased in 11 of 30 vaccinated animals. The faecal IgA 
response was measured 7 times during this period and 
there were large individual differences. The faecal IgA 
response was measured in non-vaccinated animals once 
at the end of this period. For none of those animals there 
was an increase in IgA. Faecal IgA responses are given in 
Table 3.
Faecal IgA responses were also determined in the 
period after challenge on days 3, 6, 10, 13, and 17 post 
challenge. To assess the effect of IgA on the delay of 
development of clinical SD, maximum IgA response and 
geometric mean IgA response of individual animals were 
determined and correlated to the time of onset of SD for 
that specific animal. Since delay in onset of SD was to be 
determined, only IgA values before the actual onset of 
SD for each animal were retained. Furthermore, we only 
considered seeder animals, since for receiver animals the 
time of first exposure to B. hyodysenteriae is unknown.
Non-vaccinated animals showed low levels of faecal 
IgA until onset of SD. For vaccinated seeder animals there 
was greater variability between individuals. The maxi-
mum IgA response and the geometric mean IgA response 
of those vaccinated seeder animals were significantly cor-
related to a later onset of disease (regression coefficient 
for geometric mean IgA: β = 7.26 ± 3.59 SE, p = 0.043, 
for maximum IgA response: β  =  7.59  ±  2.58  SE, 
p = 0.003). The maximum IgA and geometric mean IgA 
response, correlated with the time of onset of SD are 
shown in Figures 6 and 7.
Discussion
In the pigs inoculated with the three strongly haemolytic 
strains, a significant correlation between faecal excre-
tion of B. hyodysenteriae and faecal scores was observed. 
In the two virulence trials using the weakly haemo-
lytic strain D28, however, none of the nine animals that 
shed the strain in their faeces developed disease signs 
or lesions associated with SD. Moreover a faecal score 
of more than one was never observed and there was no 
correlation between shedding of the weakly haemolytic 
B. hyodysenteriae strain and an elevated faecal score. This 
lack of correlation was independently confirmed in the 
seeder vaccination trial, in which none of the 25 pigs that 
shed strain D28 in their faeces developed disease signs of 
SD, and no correlation between shedding of this strain 
and elevated faecal scores could be observed. All these 
Table 2 Production of serum IgG against B. hyodysenteriae before and after vaccination with the avirulent strain D28
The reaction of IgG with both the vaccination strain (D28) and the challenge strain (B204) are shown and presented as  OD450 values with standard deviation.
Group Whole cell ELISA, D28 coated Whole cell ELISA, B204 coated
Pre vaccination (day −13) Post vaccination (day 17) Pre vaccination (day −13) Post vaccination (day 17)
Vaccinated animals 0.27 ± 0.17 0.31 ± 0.13 0.25 ± 0.16 0.23 ± 0.06
Non-vaccinated animals 0.19 ± 0.14 0.23 ± 0.17 0.21 ± 0.14 0.21 ± 0.09
Table 3 Faecal IgA production before and after vaccination with the avirulent B. hyodysenteriae strain D28
The reaction of IgA with both the vaccination strain (D28) and the challenge strain (B204) are shown and presented as  OD450 values with standard deviation.
NA: not applicable.
Days post vaccination Whole cell ELISA, D28 coated Whole cell ELISA, B204 coated
Vaccinated animals Non‑vaccinated animals Vaccinated animals Non‑vaccinated animals
Day −13 0.12 ± 0.14 0.12 ± 0.28 0.11 ± 0.13 0.14 ± 0.41
Day 3 0.08 ± 0.04 NA 0.07 ± 0.03 NA
Day 5 0.15 ± 0.28 NA 0.11 ± 0.13 NA
Day 7 0.14 ± 0.15 NA 0.09 ± 0.06 NA
Day 10 0.34 ± 0.70 NA 0.13 ± 0.18 NA
Day 12 0.39 ± 0.55 NA 0.12 ± 0.09 NA
Day 14 0.66 ± 0.99 NA 0.25 ± 0.47 NA
Day 17 0.62 ± 0.96 0.11 ± 0.06 0.18 ± 0.21 0.10 ± 0.06
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results strongly indicate that the weakly haemolytic B. 
hyodysenteriae strain D28 is avirulent in pigs.
La et  al. [30] described reduced virulence in a weakly 
haemolytic B. hyodysenteriae strain obtained from a herd 
with no clinical signs of SD. In this herd, sows were pre-
sent with substantial growth of B.  hyodysenteriae strain 
JR11 in their colon, without any clinical sign of SD. 
Although true virulence potential has not yet been veri-
fied under experimental conditions, authors described 
strain JR11 as particularly innocuous [30]. Interestingly, 
strains D28 and JR11 share almost identical differences in 
their haemolysin III and haemolysin activation protein, 
as given for strain D28 earlier [23, 30]. Compared to 
the whole genome sequence of reference strain WA1 
(Accession Number NC_012225), both weakly haemo-
lytic strains JR11 and D28 show five identical amino acid 
substitutions (positions 81, 113, 164, 227, 265) in the hae-
molysin activation protein BHWA1_RS02885 and eight 
identical amino acid substitutions in the haemolysin III 
protein BHWA1_RS02195 (positions 47, 49, 56, 79, 82, 
111, 114, 133). For strain JR11 two additional amino acid 
substitutions were identified in the haemolysin III pro-
tein at positions 30 and 213. It should be noted that unin-
tentionally, for the haemolysin III protein, Table 3 in La 
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Figure 6 IgA max correlated with time of onset of SD (given in days post challenge with the virulent strain) for vaccinated seeder 
animals. X-axis presents the maximal OD450 values as measured in the ELISA.
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Figure 7 Geometric mean IgA correlated with time of onset of SD (given in days post challenge with the virulent strain) for vacci-
nated seeder animals. X-axis presents geometric mean of OD450 values as measured in the ELISA.
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et al. [30], comparing the nucleotide and amino acid dif-
ferences of strain D28 and JR11, gives the amino acid dif-
ferences from other B.  hyodysenteriae strains compared 
to WA1 and not the amino acid differences found in D28 
as given in Mahu et al. [23].
Since structural studies or deletion mutant studies are 
not available for those haemolysis associated genes, it is 
uncertain if the amino acid changes in these two strains 
indeed alter the functionality of their proteins. However, 
the unique similarity of the amino acid changes in two, 
otherwise genetically unrelated strains, that share the 
same aberrant phenotype and presumably are both low 
or avirulent, is striking.
The seeder vaccination trial described in this study 
shows that, although the number of animals that develop 
SD was not decreased in immunised animals, the 
speed of spread of SD is significantly reduced in immu-
nised animals compared to sham-immunised animals. 
Although faecal shedding after challenge was not sig-
nificantly decreased, pre-immunised animals showed 
significantly lower faecal scores compared to sham-
immunised animals. The absence of a clear IgG response 
in serum after immunisation is not surprising since it 
has been demonstrated that after experimental infection, 
serum antibody levels start to rise after 2–4 weeks and 
reach their maximum after 4–7 weeks [7]. In this experi-
ment serum samples were taken 17  days post inocula-
tion with the immunizing strain, which might have been 
too early to see a clear response. Furthermore, since this 
strain lacks virulence, epithelial damage in the colon 
can be expected to be absent. Disruption of the colonic 
mucosa during SD probably permits further penetration 
of the underlying tissues and blood vessels by bacterial 
antigen, which could enhance serum antibody response 
more intense compared to local mucosal stimulation 
alone [31].
The production of intestinal IgA may play a role in pro-
tection against SD. The delay of the onset of SD in immu-
nised pigs correlated with the presence of a substantial 
local IgA response at the moment of challenge. Earlier, 
Rees et al. [31, 32] described the presence of colonic IgA 
and IgA memory cells in gut associated lymphoid tissue 
in pigs who were re-challenged after recovering from a 
first or second challenge with B.  hyodysenteriae strain 
B204. In those studies the IgA levels in colonic washings 
or faeces were correlated with a recent exposure, but not 
with protection against development of clinical SD. This 
discrepancy with our findings is partially explained by 
the definition of protection in those earlier studies as the 
presence or absence of SD, rather than time to develop-
ment of SD, as used in the current study. Most impor-
tantly in those studies, samples were taken only once, at 
the time of necropsy, which was several weeks after the 
last exposure to B. hyodysenteriae. Indeed in our studies 
IgA in seeder vaccinated animals rose shortly after the 
exposure to the challenge strain, but in the seeder vacci-
nated animals where this rise in IgA upon challenge was 
absent, the development of SD was not delayed.
For other bacterial enteropathogens like Shigella 
flexneri, a rise in colonic IgA plays a role in induction of 
protection by immunization with live attenuated strains 
[33]. It has been shown that in order to elicit a high and 
optimal mucosal immune response, multiple doses of 
the live strain were necessary. Obviously there are differ-
ences between the pathogenesis of S. flexneri infections 
and SD, as well as between the responses of their respec-
tive hosts. However, both bacteria share the niche of the 
colon and for both bacteria, serum antibody responses 
are not linked with protection. It has been demonstrated 
on several occasions that the number of animals that is 
protected against SD is significantly higher with increas-
ing numbers of exposures to experimental challenge 
[7, 12] which would be in line with having a higher and 
prolonged mucosal immune response after multiple 
exposures.
The link between local IgA and delayed onset of SD 
opens perspectives for future vaccine development 
against B. hyodysenteriae. Some earlier studies of immu-
nity induced by experimental infection of B.  hyodysen-
teriae point to the importance of mucosal IgA [31, 32]. 
Recently there has been a developing interest in Th17 
cells and interleukin-17A (IL-17) as critical host defence 
against extracellular pathogens through upregulation of 
intestinal IgA [34]. In pigs, IL-17 is exclusively produced 
by  CD4+ and γδTCR+ T-cells. The importance of CD4+ 
cells in the immune response following B. hyodysen-
teriae infection has been described by several authors 
[15, 35]. We have demonstrated a ninefold increase in 
mRNA levels of IL-17A in SD infected pigs before [36]. 
Taken together, it would be of most interest to determine 
if CD4+ cells and upregulation of IL-17A are present in 
the colonic mucosae of pigs immunised with our strain 
D28 and to explore ways to further optimise the intes-
tinal IgA response. For example, combined parenteral 
and oral immunisation has been demonstrated to signifi-
cantly enhance mucosal IgA response for S. flexneri [37] 
and might be useful in a B. hyodysenteriae immunisation 
regime as well.
In conclusion, we describe the lack of virulence of 
the weakly haemolytic B.  hyodysenteriae strain D28. 
Immunisation of pigs by oral inoculation of this strain, 
significantly slows down the spread of SD compared 
to sham-immunised animals in a seeder challenge 
model. This protection was associated with a strong IgA 
response upon challenge, providing directions for future 
vaccine development.
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